Constantin Sorlescu, INREV, John Ravoisin, PwC, Nick Brown, M&G Real Estate, Robert White, EY and John Forbes, John Forbes Consulting, discussed the recently launched Open End Fund Pricing consultation paper, including a highly relevant section in today’s uncertain times related to pricing policy during exceptional market circumstances.
There’s broad agreement within the industry that we need to establish a more structured and common approach to pricing policies. To accelerate the debate INREV and AREF are pleased to present a consultation on Open End Fund Pricing.
Through the global non-listed partnership, The INREV / ANREV / NCREIF alliance advances the global agenda of transparency, accessibility and professionalism to increase harmonization across the non-listed real estate industry globally.
This short paper provides non-listed real estate investors with a pocket guide to the secondary markets; its uses, benefits as well as some important considerations that should be taken into account as we prepare for the new wave of challenges related to COVID-19.
Constantin Sorlescu, Director of Professional Standards at INREV joined by Renaud Breyer, Partner at EY Luxembourg, and Andrew Muscat, COO/CFO at LaSalle Global Partner Solutions, shows you how to calculate TGER, including treatment and allocation of its main components, and how to make the transition from TER to TGER to ensure compliance with the INREV Guidelines.
During the briefing, Constantin Sorlescu, INREV together with Thomas Kallenbrunnen, PGIM Real Estate, Nick Brown, M&G Real Estate, John Ravoisin, PwC and Robert White, EY discuss:
- Liquidity requirements and secondary markets
- Terms and rights of redemptions
- Transparency and disclosures regarding pricing policy
Constantin Sorlescu, INREV will be joined by John Ravoisin, PwC and Renaud Breyer, EY provide guidance and considerations that may be appropriate for investment managers when reporting to investors in these uncertain times. Also read a short paper filled with reporting considerations related to COVID-19 and which are based on the INREV Guidelines.